New offering to refresh & enhance workplace Mental Health and Talent programs: Brain Health At Work

Does this sound famil­iar? Rush and mul­ti­task­ing every­where, yet we’re see­ing low pro­duc­tiv­i­ty and high burnout because we’re not tak­ing good care of our brain’s health. Peo­ple aren’t real­ly con­nect­ing with the old-school, med­ical ways of tack­ling Men­tal Health that just focus on what’s wrong. Employ­ees are often wary of tak­ing on new demand­ing tasks,…

Read More

New book encourages readers to embrace uncertainty in order to improve decision-making, mental health, and more

Life is uncer­tain. We nev­er know what will hap­pen, and many things are unknow­able. This can make us feel stressed or wor­ried, since the unknown is asso­ci­at­ed with dan­ger. But as jour­nal­ist Mag­gie Jack­son argues in her new book, Uncer­tain: The Wis­dom and Won­der of Being Unsure, there are many ben­e­fits to allow­ing our­selves to…

Read More

Executive Functions and Dysfunction in Brain Health and Brain Disorders: Dates announced for Dr. Elkhonon Goldberg’s Symposium in Costa Rica

We are pleased to announce a fan­tas­tic 5‑day pro­fes­sion­al devel­op­ment oppor­tu­ni­ty fea­tur­ing our Advi­sor and renowned author and neu­ropsy­chol­o­gist Elkhonon Gold­berg, Ph.D., ABPP., and titled “Exec­u­tive Func­tions and Dys­func­tion in Brain Health and Brain Dis­or­ders. Frontal Lobes, Dis­trib­uted Net­works, and the Whole Brain.” The infor­ma­tion pre­sent­ed will aid prac­ti­tion­ers and researchers alike in advanc­ing their knowledge…

Read More

Systematic review finds more clinical harm than benefits in Alzheimer’s “treatments” lecanemab, aducanumab, and donanemab

Study ques­tions ben­e­fit of new Alzheimer’s drug (UGA Today): Last sum­mer, the U.S. Food and Drug Admin­is­tra­tion ful­ly approved the first drug shown to slow the progress of Alzheimer’s. But new research from the Uni­ver­si­ty of Geor­gia sug­gests that patients and care­givers may not expe­ri­ence any ben­e­fit from the drug in their dai­ly lives. The drug, Leqembi,…

Read More

Brain Health in 2030: Navigating Neuroplasticity & the Digital Health Market

Brain Health in 2030: Nav­i­gat­ing Neu­ro­plas­tic­i­ty & the Dig­i­tal Health Mar­ket from Sharp­Brains Keynote deliv­ered by Álvaro Fer­nán­dez, CEO of Sharp­Brains, dur­ing cor­po­rate retreat. Key mes­sage: Our very human brains and minds are the most sophis­ti­cat­ed tech­nol­o­gy at our dis­pos­al, so we should invest more time learn­ing about how they work and har­ness­ing neu­ro­­plas­tic­i­­ty-based methods…

Read More